Kirin is looking to back innovations in metabolic health, immunity and brain function, fermentation and microbiota control, and consumer health data technology through its startup innovation fund.
Kirin has invested in local women’s health brand Wray through its innovation fund aimed at supporting start-ups with innovative and unique technologies.
From Clorox to Kirin to Johnson & Johnson, this year we’ve seen several consumer packaged goods (CPG) giants enter the dietary supplement space, either through acquisitions or major investments.
A division of China's state-run investment fund is believed to be among the front runners to snap up Australian vitamin maker Nature's Care, as it embarks on its second sale attempt with a price tag of around $1bn.
New Zealand supplement and health food manufacturers are likely targets for merger and acquisition activity over the next year, with private equity firms, notably from China, increasingly looking to splash the cash.
Hyderabad-based nutritional supplements maker Genmedic Healthcare Pvt Ltd received an investment boost from the ad-for-equity investment arm of media firm Bennett, Coleman and Company Ltd (BCCL), Brand Capital.
A Chinese financial website and a private equity fund have sealed a deal to raise capital form mainland China to invest in the US cannabis supplements and functional beverage sectors.
In the first of a two-part interview, DuPont’s Asia president for health and nutrition Dr Li Yongjing discusses the initial turbulence created by the ongoing merger with Dow, and explains why he believes the new relationship will make the firm better...